BioAge Labs, Inc.
Q4 2025 13F Holders
Symbol
BIOA
CUSIP
09077V100
Type
Equity
Class
COM
Num filings
119
Total reported value, excl. options
$315 M
Compare 2025 Q4 to
2026 Q3
2026 Q2
2026 Q1
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type